Seed Therapeutics

Seed Therapeutics is pioneering the science of improving human health by creating molecular glues: novel therapeutics that degrade disease-causing proteins that have heretofore remained undruggable. Through ongoing collaborations with world-leading academic experts in the field, and in partnership with seasoned drug development and commercialization experts, Seed Therapeutics is establishing a growing pipeline of exciting drug candidates on a path to clinical and commercial success. Our mission is to positively impact human health by creating novel protein degradation therapeutics for the treatment of severe diseases for which health care professionals currently have limited options to offer to patients

Biotechnology,biotherapeutics,cell biology,protein chemistry,cell pharmacology ,molecular biology,protein degradation,molecular glue,and targeted protein degradation

Seed therapeutics operates in the Biotechnology research industry.

Seed therapeutics's revenue is 11m - 100m

Seed therapeutics has 11 - 50 employees.